QIAGEN N.V. Plans for Q3 2024 Results Release
QIAGEN N.V. (NYSE: QGEN) has exciting updates regarding its third quarter 2024 results. The global leader in Sample to Insight solutions for molecular diagnostics and life sciences is gearing up for a comprehensive announcement.
Release and Webcast Details
The upcoming results will be released on a Wednesday, shortly after the 22:05 Frankfurt time, aligning with 21:05 London time and 16:05 New York time. This timings caters to a worldwide audience, inviting stakeholders and interested parties globally to stay in the loop regarding developments at QIAGEN.
Conference Call Information
Following the results release, a conference call is scheduled for Thursday at 15:30 Frankfurt time, 14:30 London time, and 09:30 New York time. This interactive session will provide an in-depth opportunity for analysts and investors to understand the intricacies behind the financial results.
Three Easy Ways to Join the Call
QIAGEN offers several convenient options for participants to engage in the conference call:
- Connect via Callback: Participants can register for a call back connection. Simply click the link to fill in your details for a seamless connection to the conference.
- Dial-in By Phone: For those who prefer a direct approach, dialing in is available. U.S. participants can reach +1 929 477 0448, UK residents can call +44 (0)330 165 3655, and callers from Germany can connect at +49 (0)69 6610 2492. Use Conference ID 8002609 to ensure your call is directed properly. It's advisable to join a few minutes early to avoid delays.
- Access the Audio Webcast: Those who prefer an online experience can easily access the audio webcast through a dedicated link, providing a straightforward means to follow the call live.
Replay Availability
Participants who miss the live session need not worry. A replay of the conference call will be readily accessible post-event, ensuring everyone has the chance to stay informed regardless of their availability.
About QIAGEN N.V.
As a prominent Netherlands-based holding company, QIAGEN N.V. is committed to empowering customers with valuable molecular insights from various sample types. By providing cutting-edge technologies that isolate, process, and analyze DNA, RNA, and proteins, QIAGEN supports sectors ranging from human healthcare to academia and industrial applications. Innovative automation solutions enhance efficiency, making QIAGEN a preferred partner for over 500,000 customers worldwide.
With a dedicated workforce exceeding 5,900 employees spread across 35 locations globally, QIAGEN continues to expand its reach and impact. Those interested in deeper insights about the company and its offerings can find more details on their official website.
Frequently Asked Questions
What is the purpose of the Q3 2024 results release?
The results release provides stakeholders with essential financial performance updates, helping them assess QIAGEN's progress and strategies.
When will the conference call take place?
The conference call is scheduled for Thursday at 15:30 Frankfurt time, allowing participants to dive deeper into the financial results.
How can I access the audio webcast?
Participants can access the audio webcast through a provided link, ensuring a straightforward method to follow the proceedings live.
Will there be a replay of the conference call?
Yes, a replay will be made available after the call, allowing those who missed it to catch up on the discussions and insights shared.
What does QIAGEN specialize in?
QIAGEN specializes in providing Sample to Insight solutions, enabling the efficient processing and analysis of biological samples for healthcare and research applications.